Your Safety First: What You Need to Know About Bionpharma’s Urgent Atovaquone Recall
WASHINGTON, D.C. — Bionpharma Inc. this week announced a voluntary recall of a single batch of Atovaquone Oral Suspension, 750mg per mL, due to contamination with Cohnella bacteria. This recall, …
Your Safety First: What You Need to Know About Bionpharma’s Urgent Atovaquone Recall Read More